| 标题 |
Phase I, randomized, double-blind, single-dose study to assess the pharmacokinetics, safety, and immunogenicity of the proposed biosimilar SCT630 and adalimumab in healthy Chinese subjects |
| 网址 | |
| DOI | |
| 其它 |
期刊:International Immunopharmacology 作者:Long Liu; Lu Qi; Chunpu Lei; Yu Wang; Wei Zhang; et al 出版日期:2022-02-19 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)